HCPCS Level IIdrugActive
J7402
Mometasone sinus sinuva
BETOS: O1E
Effective: 2021-04-01
Referenced in 1 policies
Description
Mometasone furoate sinus implant, (sinuva), 10 micrograms
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Sinuva
Manufacturer
Intersect ENT, INC.
HCPCS Dosage
10 MCG
Billing Units
135.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.